In line with this, drug resistant SKOV3 cells, which were grown continuously in low doses of cis + pax treatment for >2 weeks, expressed high levels of Brn-3b, suggesting that this regulator may have potential roles in the acquisition of drug resistance in ovarian cancer cells. Here, POU4F2 is linked to ovarian cancer.